Effect of Aromatase Inhibitors on Ultrasonographic Measurements and Static and Dynamic Balance Scores in Breast Cancer

Breast Density Change Predicting Response to Adjuvant Aromatase Inhibitor

NCT01765049 ·Status: ACTIVE_NOT_RECRUITING

Effects of Adjuvant Endocrine Therapy With Aromatase Inhibitors on the Postoperative Lipid Levels in Postmenopausal Breast Cancer Patients

NCT02765373 ·Status: UNKNOWN

Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.

NCT00287534 ·Status: COMPLETED ·Phase: PHASE2

Bone Geometry and Muscle Density Changes in Postmenopausal Women and Breast Cancer Patients Prescribed Anastrozole

NCT00421447 ·Status: COMPLETED

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)

NCT04436744 ·Status: COMPLETED ·Phase: PHASE2

Exercise to Prevent Aromatase Inhibitor Side Effects in Breast Cancer Patients

NCT01954706 ·Status: TERMINATED ·Phase: NA

Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole

NCT00316836 ·Status: COMPLETED

Liver Safety Under Upfront Arimidex vs Tamoxifen

NCT00537771 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of Blood/Imaging Based Biomarkers, Aromatase Inhibitor Induced Musculoskeletal Syndrome

NCT03665077 ·Status: COMPLETED ·Phase: NA

Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"

NCT05103644 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

The Anti-tumor Effect of Metformin And Atorvastatin in Breast Cancer

NCT05507398 ·Status: UNKNOWN ·Phase: PHASE4

Physical Activity to Reduce Joint Pain During Aromatase Inhibitor Therapy

NCT01900418 ·Status: COMPLETED ·Phase: NA

Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor Therapy

NCT00784888 ·Status: COMPLETED

Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer

NCT03351062 ·Status: RECRUITING ·Phase: PHASE3

Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients

NCT02995772 ·Status: COMPLETED ·Phase: PHASE3

Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer

NCT02278120 ·Status: COMPLETED ·Phase: PHASE3

Arthralgia During Anastrozole Therapy for Breast Cancer

NCT00323479 ·Status: COMPLETED ·Phase: PHASE4

A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Postmenopausal Breast Cancer Patients

NCT03543072 ·Status: UNKNOWN

Clinical Trial Evaluating the Efficacy and Implementation of an Early Adapted Physical Activity to Prevent and Manage Aromatase Inhibitor-induced Musculoskeletal Pain in Breast Cancer (APIS)

NCT07295457 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Cohort Study of Musculoskeletal Health in Patients With Breast Cancer During Aromatase Inhibitors Therapy

NCT05921617 ·Status: UNKNOWN

This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.

NCT05439499 ·Status: UNKNOWN ·Phase: PHASE3

Impact of Chemotherapy Followed by Aromatase Inhibitors on Bone Health of Women With ER-positive Early Breast Cancer

NCT01298362 ·Status: COMPLETED

Effects of Aromatase Inhibitor Therapy on Muscle Function

NCT03581552 ·Status: COMPLETED

Interactive Care Plan for the Monitoring of Symptoms and Recovery in Patients With Stage 0-III Breast Cancer

NCT04693338 ·Status: COMPLETED ·Phase: PHASE1

Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer

NCT02097459 ·Status: UNKNOWN ·Phase: PHASE3